EGFR plays an important role in the progression and development of several cancers in humans, on an average 50–60% of lung adenocarcinoma, colon cancer, and breast carcinoma (Pabla et al., 2015; Sigismund et al., 2018). This evidence concerns the gene EGFR and breast carcinoma.